Leading player in the domestic market: With market share of around 5%, Cipla is ranked 2nd in the Indian pharma market. Banking on the strength of its large number of medical representatives (MR), the company has been successful in capturing a sizeable chunk of market share in various therapies.
Returns over 1 year are compounded annual averages * BSE Sensex
Shareholding (Sep-12)
Category(%)Promoters36.8 Banks, MFs and FIs13.4
FIIs20.8 Indian public19.0Others10.0
For Daily Update & Profit Join With Us :-
Lakshya Profit
lakshyai@yahoo.com
| Stock price performance | ||
| Cipla | Index* | |
| 1-Yr | 26.0% | 8.5% |
| 3-Yrs | 8.3% | 3.8% |
| 5-Yrs | 14.3% | -0.1% |
Shareholding (Sep-12)
Category(%)Promoters36.8 Banks, MFs and FIs13.4
FIIs20.8 Indian public19.0Others10.0
For Daily Update & Profit Join With Us :-
Lakshya Profit
lakshyai@yahoo.com
No comments:
Post a Comment
Note: only a member of this blog may post a comment.